America wants to reduce its reliance on Chinese supply chains, since it remains in a trade war that is only temporarily on ...

CHICAGO — With the skyrocketing of prices of new cancer drugs, the buzz word within oncology circles has become "value," with consideration given to the cost of therapy and to clinical benefits and ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect. The compound was developed by Lawrence Livermore National ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth. Lung cancer, specifically Non-Small Cell Lung Cancer (NSCLC)-the most common ...

Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing cancer drugs. The research suggests that targeting multiple types of brain ...

FDA reviewers flagged trial uncertainties for nearly 80% of cancer drugs approved from 2019 to 2022, but few were reported in journals or National Comprehensive Cancer Network (NCCN) guidelines. The ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer's, potentially slowing or even ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life. By Gina Kolata Breast cancer patients whose tumors have ...